New York (CNN Business) — Weeks after Russian tanks rolled into Ukraine in early 2022, a North Carolina biotech company that has done work for the Pentagon scrambled to help civilians and soldiers wounded by the war. Nasdaq-listed Humacyte, which is developing a platform designed to harness the body’s own…Read More
Alleged Russian crime boss sanctioned by Ukraine owns a major stake in US biotech firm KION546
